Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smoking Cessation and Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema

NCT03382106 is registered in ClinicalTrials.gov with Eric A. Hoffman as lead sponsor.

NCT NCT03382106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03382106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smoking Cessation and Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
Lead sponsor
Eric A. Hoffman
Phase
Phase 4
Overall status
Completed
Start date
March 19, 2018
Completion date
September 24, 2024
Enrollment
162 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema